SCHEMBL7535772

SCHEMBL7535772

Fc1ccc(N(c2ccc(N(c3ccc(F)cc3)c3nccs3)cc2)c2nccs2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FBP1 P09467 2/20 0.47
NPC1 O15118 4/20 0.40
RAB9A P51151 4/20 0.40
KMT2A Q03164 2/20 0.40
PKM P14618 1/20 0.40
ALDH1A1 P00352 4/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
GAA P10253 2/20 0.38
NFKB1 P19838 1/20 0.38
AGTR1 P30556 1/20 0.38
HTT P42858 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
PTGDR2 Q9Y5Y4 3/20 0.36
CYP1A2 P05177 2/20 0.36
SYK P43405 1/20 0.36
CYP1A1 P04798 1/20 0.36
CYP1B1 Q16678 1/20 0.36
LMNA P02545 1/20 0.35
MAPK14 Q16539 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2975777 0.81 FBP1 (0.41) FBP1NPC1RAB9AKMT2APKM
SCHEMBL9305341 0.80 PDPK1 (0.45) FBP1NPC1RAB9AKMT2APKM
SCHEMBL3886947 0.74 MEN1 (0.50) NPC1RAB9AKMT2APKMALDH1A1
SCHEMBL2983284 0.73 FFAR1 (0.41) FBP1NPC1RAB9AKMT2APKM
SCHEMBL6798397 0.72 PDPK1 (0.38) FBP1NPC1RAB9AKMT2APKM
SCHEMBL18939227 0.71 LMNA (0.46) NPC1RAB9AKMT2AALDH1A1SMN1; SMN2
SCHEMBL26101042 0.71 RBBP9 (0.41) NPC1RAB9AKMT2APKMALDH1A1
SCHEMBL330278 0.69 CHRM2 (0.39) FBP1NPC1RAB9AKMT2APKM
SCHEMBL4305587 0.68 APP (0.44) ALDH1A1GAAHTTPTGDR2CYP1A2
SCHEMBL4589649 0.65 PDPK1 (0.63) FBP1NPC1RAB9AKMT2APKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6391894-B1 ANTICANCER AGENTS; ANTIPROLIFERATIVE AGENTS SMITHKLINE BEECHAM CORPORATION 2002-05-21 US claimed
EP-1137415-A4 MYT1 KINASE INHIBITORS SMITHKLINE BEECHAM CORP (US) 2002-03-20 EP claimed
EP-1137415-A1 MYT1 KINASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2001-10-04 EP claimed
WO-2000033842-A1 MYT1 KINASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2000-06-15 WO claimed
US-6391894-B1 ANTICANCER AGENTS; ANTIPROLIFERATIVE AGENTS SMITHKLINE BEECHAM CORPORATION 2002-05-21 US disclosed